BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 33593308)

  • 1. Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis.
    Khan M; Zhao Z; Arooj S; Liao G
    BMC Cancer; 2021 Feb; 21(1):167. PubMed ID: 33593308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience.
    Sadraei NH; Dahiya S; Chao ST; Murphy ES; Osei-Boateng K; Xie H; Suh JH; Peereboom DM; Stevens GH; Ahluwalia MS
    Am J Clin Oncol; 2015 Jun; 38(3):304-10. PubMed ID: 23799286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bevacizumab Treatment of Radiation-Induced Brain Necrosis: A Systematic Review.
    Liao G; Khan M; Zhao Z; Arooj S; Yan M; Li X
    Front Oncol; 2021; 11():593449. PubMed ID: 33842309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery.
    Boothe D; Young R; Yamada Y; Prager A; Chan T; Beal K
    Neuro Oncol; 2013 Sep; 15(9):1257-63. PubMed ID: 23814264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases.
    Glitza IC; Guha-Thakurta N; D'Souza NM; Amaria RN; McGovern SL; Rao G; Li J
    Melanoma Res; 2017 Dec; 27(6):580-584. PubMed ID: 28817446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A Randomized Controlled Trial.
    Xu Y; Rong X; Hu W; Huang X; Li Y; Zheng D; Cai Z; Zuo Z; Tang Y
    Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1087-1095. PubMed ID: 29885994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser interstitial thermal therapy (LITT) vs. bevacizumab for radiation necrosis in previously irradiated brain metastases.
    Sujijantarat N; Hong CS; Owusu KA; Elsamadicy AA; Antonios JP; Koo AB; Baehring JM; Chiang VL
    J Neurooncol; 2020 Jul; 148(3):641-649. PubMed ID: 32602021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Variables for Prediction of the Therapeutic Effects of Bevacizumab Monotherapy in Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
    Li Y; Huang X; Jiang J; Hu W; Hu J; Cai J; Rong X; Cheng J; Xu Y; Wu R; Luo J; Tang Y
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):621-629. PubMed ID: 29413276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab for radiation necrosis following treatment of high grade glioma: a systematic review of the literature.
    Lubelski D; Abdullah KG; Weil RJ; Marko NF
    J Neurooncol; 2013 Dec; 115(3):317-22. PubMed ID: 24005770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.
    Dashti SR; Spalding A; Kadner RJ; Yao T; Kumar A; Sun DA; LaRocca R
    J Neurosurg Pediatr; 2015 Jan; 15(1):20-5. PubMed ID: 25360851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bevacizumab vs laser interstitial thermal therapy in cerebral radiation necrosis from brain metastases: a systematic review and meta-analysis.
    Palmisciano P; Haider AS; Nwagwu CD; Wahood W; Aoun SG; Abdullah KG; El Ahmadieh TY
    J Neurooncol; 2021 Aug; 154(1):13-23. PubMed ID: 34218396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature.
    Delishaj D; Ursino S; Pasqualetti F; Cristaudo A; Cosottini M; Fabrini MG; Paiar F
    J Clin Med Res; 2017 Apr; 9(4):273-280. PubMed ID: 28270886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients.
    Wang Y; Pan L; Sheng X; Mao Y; Yao Y; Wang E; Zhang N; Dai J
    Eur J Med Res; 2012 Aug; 17(1):25. PubMed ID: 22913802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevacizumab treatment leads to observable morphological and metabolic changes in brain radiation necrosis.
    Yonezawa S; Miwa K; Shinoda J; Nomura Y; Asano Y; Nakayama N; Ohe N; Yano H; Iwama T
    J Neurooncol; 2014 Aug; 119(1):101-9. PubMed ID: 24789256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma.
    Vaios EJ; Batich KA; Buckley AF; Dunn-Pirio A; Patel MP; Kirkpatrick JP; Goudar R; Peters KB
    Oncotarget; 2022; 13():576-582. PubMed ID: 35359747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and International Stereotactic Radiosurgery Society Recommendations.
    Vellayappan B; Lim-Fat MJ; Kotecha R; De Salles A; Fariselli L; Levivier M; Ma L; Paddick I; Pollock BE; Regis J; Sheehan JP; Suh JH; Yomo S; Sahgal A
    Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):14-28. PubMed ID: 37482137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab in the treatment of radiation injury for children with central nervous system tumors.
    Dahl NA; Liu AK; Foreman NK; Widener M; Fenton LZ; Macy ME
    Childs Nerv Syst; 2019 Nov; 35(11):2043-2046. PubMed ID: 31367784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts.
    Li J; He J; Cai L; Lai M; Hu Q; Ren C; Wen L; Wang J; Zhou J; Zhou Z; Li S; Ye M; Shan C; Chen L; Zhou C
    Ann Palliat Med; 2021 Feb; 10(2):2018-2026. PubMed ID: 33549015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single low-dose targeted bevacizumab infusion in adult patients with steroid-refractory radiation necrosis of the brain: a phase II open-label prospective clinical trial.
    Dashti SR; Kadner RJ; Folley BS; Sheehan JP; Han DY; Kryscio RJ; Carter MB; Shields LBE; Plato BM; La Rocca RV; Spalding AC; Yao TL; Fraser JF
    J Neurosurg; 2022 Dec; 137(6):1676-1686. PubMed ID: 35426830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab as a treatment option for radiation-induced cerebral necrosis.
    Matuschek C; Bölke E; Nawatny J; Hoffmann TK; Peiper M; Orth K; Gerber PA; Rusnak E; Lammering G; Budach W
    Strahlenther Onkol; 2011 Feb; 187(2):135-9. PubMed ID: 21336713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.